Summary by Futu AI
New Ray Medic International Holdings Limited ("New Ray Medic") held a special shareholders' meeting on July 16, 2024, at which an ordinary resolution was passed. The resolution involved approving a purchase agreement and the transactions thereunder, and authorizing any director to deal with related matters. Of the shareholders present at the meeting, 429,438,400 stocks (100% of the shares held by the attending shareholders) voted in favor, with no votes against. The passage of this resolution allowed the company to proceed with the relevant transaction. On the day of the special shareholders' meeting, the company had issued a total of 1,671,846,657 shares, and the company did not hold any treasury shares. All directors were present in person or electronically, and no shareholder was required to abstain from voting or indicate opposition to the resolution. The scrutineer for the special shareholders' meeting was Zhuojia Securities Registration Co., Ltd. Ms. Wang Qiuqin, the chairman, chief executive officer and executive director of New Ray Medic, issued an announcement after the meeting.
